Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phosphorylation abnormalities: NZB mice exhibit a B-cell signalling defect.

Joseph M Tuscano1, Tom C Hsu, Hayes McKnight

  • 1Department of Hematology, University of California at Davis Medical Center, Sacramento, CA 95817, USA.

Journal of Autoimmunity
|November 7, 2002
PubMed
Summary

NZB mice, a model for lupus disease, show B-cell hyperactivity due to impaired signaling. This stems from reduced phosphatase activity and altered protein phosphorylation in B-cell activation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.

Blood advances·2026
Same author

Phase I Study of Mogamulizumab in Combination with Pembrolizumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma-A National Cancer Institute Experimental Therapeutics Clinical Trials Network (NCI-ETCTN) Trial.

Cancers·2026
Same author

IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell Injury.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.

Blood advances·2025
Same author

Lymphoma Therapy Response Assessment with Low-Dose [<sup>18</sup>F]FDG Total-Body PET/CT.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Light chain crystalline podocytopathy caused by electron-lucent crystals - a diagnostic challenge: a case report.

Ultrastructural pathology·2025

Area of Science:

  • Immunology
  • Molecular Biology
  • Autoimmune Diseases

Background:

  • NZB mice are a key genetic model for studying systemic lupus erythematosus.
  • Lupus is characterized by hyperactive B cells producing autoantibodies, leading to hypergammaglobulinaemia.
  • B-cell receptor signaling is crucial for immune response regulation.

Purpose of the Study:

  • To investigate the intrinsic defects in B-cell signaling pathways in NZB mice.
  • To identify molecular abnormalities contributing to B-cell hyperactivity in this lupus model.

Main Methods:

  • Analysis of B-cell activation and signaling in NZB mice.
  • Assessment of phosphatase activity and tyrosine phosphorylation levels in B cells.
  • Examination of specific signaling molecules like SAPK and SHIP-1.

Related Experiment Videos

Main Results:

  • NZB mouse B cells exhibit hyperactivity upon B-cell receptor stimulation.
  • A significant reduction in phosphatase activity was observed in NZB B cells.
  • Elevated tyrosine phosphorylation levels and abnormal phosphorylation of SAPK and SHIP-1 were detected.

Conclusions:

  • Intrinsic defects in B-cell signaling pathways, particularly reduced phosphatase activity, contribute to B-cell hyperactivity in NZB mice.
  • These molecular abnormalities provide insights into the pathogenesis of lupus-like disease in this model.
  • Targeting these signaling pathways may offer therapeutic strategies for lupus.